Sunshine Biopharma (SBFMW) Return on Sales (2016 - 2025)
Historic Return on Sales for Sunshine Biopharma (SBFMW) over the last 10 years, with Q3 2025 value amounting to 0.09%.
- Sunshine Biopharma's Return on Sales rose 500.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.15% for FY2024, which is 400.0% up from last year.
- According to the latest figures from Q3 2025, Sunshine Biopharma's Return on Sales is 0.09%, which was up 500.0% from 0.19% recorded in Q2 2025.
- Sunshine Biopharma's Return on Sales' 5-year high stood at 7.84% during Q4 2021, with a 5-year trough of 154.4% in Q1 2021.
- Its 5-year average for Return on Sales is 16.5%, with a median of 0.19% in 2025.
- Its Return on Sales has fluctuated over the past 5 years, first tumbled by -1361500bps in 2021, then soared by 1443200bps in 2022.
- Sunshine Biopharma's Return on Sales (Quarter) stood at 7.84% in 2021, then crashed by -176bps to 5.97% in 2022, then soared by 97bps to 0.16% in 2023, then tumbled by -38bps to 0.22% in 2024, then skyrocketed by 58bps to 0.09% in 2025.
- Its last three reported values are 0.09% in Q3 2025, 0.19% for Q2 2025, and 0.13% during Q1 2025.